These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1002996

  • 1. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    Fernandez HN, Hugli TE.
    J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
    [Abstract] [Full Text] [Related]

  • 2. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC, Hugli TE.
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [Abstract] [Full Text] [Related]

  • 3. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN, Hugli TE.
    J Biol Chem; 1978 Oct 10; 253(19):6955-64. PubMed ID: 690134
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 10; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 5. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C, Hugli TE.
    Proc Natl Acad Sci U S A; 1981 Mar 10; 78(3):1833-7. PubMed ID: 6940191
    [Abstract] [Full Text] [Related]

  • 6. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD, Chenoweth DE, Goldstein IM.
    J Clin Invest; 1986 Dec 10; 78(6):1589-95. PubMed ID: 3782473
    [Abstract] [Full Text] [Related]

  • 7. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW.
    J Clin Invest; 1979 Sep 10; 64(3):804-11. PubMed ID: 89118
    [Abstract] [Full Text] [Related]

  • 8. Complete covalent structure of human platelet factor 4.
    Morgan FJ, Begg GS, Chesterman CN.
    Thromb Haemost; 1980 Feb 29; 42(5):1652-60. PubMed ID: 6445090
    [Abstract] [Full Text] [Related]

  • 9. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP, Hugli TE, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1979 Oct 29; 76(10):5299-302. PubMed ID: 291947
    [Abstract] [Full Text] [Related]

  • 10. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE, Vallota EH, Müller-Eberhard HJ.
    J Biol Chem; 1975 Feb 25; 250(4):1472-8. PubMed ID: 803505
    [Abstract] [Full Text] [Related]

  • 11. The active site of human C4a anaphylatoxin.
    Hugli TE, Kawahara MS, Unson CG, Molinar-Rode R, Erickson BW.
    Mol Immunol; 1983 Jun 25; 20(6):637-45. PubMed ID: 6603573
    [Abstract] [Full Text] [Related]

  • 12. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J, Hugli TE, Smedegård G.
    J Immunol; 1985 Feb 25; 134(2):1115-9. PubMed ID: 3871207
    [Abstract] [Full Text] [Related]

  • 13. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Feb 25; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 14. Biochemistry and biology of anaphylatoxins.
    Hugli TE.
    Complement; 1986 Feb 25; 3(3):111-27. PubMed ID: 3542363
    [Abstract] [Full Text] [Related]

  • 15. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
    Zimmermann B, Damerau B, Vogt W.
    Hoppe Seylers Z Physiol Chem; 1980 Feb 25; 361(6):915-24. PubMed ID: 7399411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 19. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S, Glovsky MM, Kunkel SL.
    Int Arch Allergy Appl Immunol; 1987 Nov 15; 82(1):4-9. PubMed ID: 3492446
    [Abstract] [Full Text] [Related]

  • 20. Structure and function of the anaphylatoxins.
    Hugli TE.
    Springer Semin Immunopathol; 1984 Nov 15; 7(2-3):193-219. PubMed ID: 6387982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.